» Articles » PMID: 7690411

Influence of Epitope Polarity and Adjuvants on the Immunogenicity and Efficacy of a Synthetic Peptide Vaccine Against Semliki Forest Virus

Overview
Journal J Virol
Date 1993 Oct 1
PMID 7690411
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The antibody response to a previously defined B-cell epitope of Semliki Forest virus (SFV) was investigated in male BALB/c (H-2d) mice. The B-cell epitope, located at amino acid positions 240 to 255 of the E2 protein, was linked to an H-2d-restricted T-helper cell epitope of SFV located at positions 137 to 151 of the E2 protein. Colinearly synthesized peptides, of either T-B or B-T polarity, mixed with different adjuvants (the nonionic block copolymer L 180.5, a water-oil-water [W/O/W] emulsion of L 180.5, Montanide, and Q VAC) were used for immunization. Generally, after one booster immunization, high serum antibody titers were measured against either peptide. With Q VAC and W/O/W L 180.5 as adjuvants, the titers of SFV-reactive (nonneutralizing) antibodies were consistently much higher after immunization with the T-B peptide than with the B-T peptide, which was reflected in a higher vaccine efficacy. With these two adjuvants, the survival ratio in T-B peptide-immunized mice was 82%, compared with 8% in B-T peptide-immunized mice. Intermediate results were obtained with the adjuvant Montanide. L 180.5 alone was ineffective in this study. All immunoglobulin G (IgG) isotypes were induced with either adjuvant, but Q VAC was clearly the most effective in inducing IgG2a and IgG2b isotypes with the T-B peptide as the antigen. Subsequently, monoclonal antibodies (MAbs) of IgM, IgG1, IgG2a, IgG2b, and IgG3 subclasses were prepared against the B-cell epitope. These nonneutralizing but SFV-reactive MAbs protected 40 to 80% of mice against a lethal challenge with SFV. Control mice all died. The availability of those antipeptide MAbs allowed competition binding assays with a previously characterized panel of E2-specific MAbs. Binding of enzyme-labeled antipeptide MAbs was very effectively inhibited by two strongly SFV-neutralizing mutually competitive MAbs, suggesting that the linear B-cell epitope (amino acids 240 to 255) is associated with a major neutralization site of SFV.

Citing Articles

Bcipep: a database of B-cell epitopes.

Saha S, Bhasin M, Raghava G BMC Genomics. 2005; 6:79.

PMID: 15921533 PMC: 1173103. DOI: 10.1186/1471-2164-6-79.


Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.

Caro-Aguilar I, Rodriguez A, Calvo-Calle J, Guzman F, De La Vega P, Patarroyo M Infect Immun. 2002; 70(7):3479-92.

PMID: 12065487 PMC: 128085. DOI: 10.1128/IAI.70.7.3479-3492.2002.


Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.

Goetsch L, Huss T, Champion T, Beck A, Haeuw J, Nguyen T J Virol. 1999; 73(7):5637-45.

PMID: 10364313 PMC: 112622. DOI: 10.1128/JVI.73.7.5637-5645.1999.


Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

AlonsoDeVelasco E, Verheul A, Verhoef J, Snippe H Microbiol Rev. 1995; 59(4):591-603.

PMID: 8531887 PMC: 239389. DOI: 10.1128/mr.59.4.591-603.1995.


The potential of immunization with synthetic peptides to overcome the immunosuppressive effect of maternal anti-measles virus antibodies in young mice.

Obeid O, Steward M Immunology. 1994; 82(1):16-21.

PMID: 8045592 PMC: 1414851.

References
1.
Nakane P, Kawaoi A . Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem. 1974; 22(12):1084-91. DOI: 10.1177/22.12.1084. View

2.
Garoff H, Frischauf A, Simons K, Lehrach H, Delius H . Nucleotide sequence of cdna coding for Semliki Forest virus membrane glycoproteins. Nature. 1980; 288(5788):236-41. DOI: 10.1038/288236a0. View

3.
Schmaljohn A, Johnson E, Dalrymple J, Cole G . Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature. 1982; 297(5861):70-2. DOI: 10.1038/297070a0. View

4.
Moller E . Adjuvants influence the immunoglobin subclass distribution of immune responses in vivo. Scand J Immunol. 1984; 19(3):219-25. DOI: 10.1111/j.1365-3083.1984.tb00923.x. View

5.
Boere W, Harmsen T, Vinje J, Benaissa-Trouw B, Kraaijeveld C, Snippe H . Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities. J Virol. 1984; 52(2):575-82. PMC: 254560. DOI: 10.1128/JVI.52.2.575-582.1984. View